Clinical trial Recruiting at 2 sites Interventional Ages 18 to 70

TelTex4BP: A mobile program to help adults with hypertension in Nepal

Official title: Effectiveness and Adoption of the Structured mHealth Intervention for Improving Blood Pressure Control (TelTex4BP) Among Adults With Hypertension in Nepal: A Randomized Controlled Trial

Run by Central Department of Public Health · NCT05979168 · Data updated 2026-11-12

A mobile text and phone-based program (TelTex4BP) helps adults with high blood pressure in Nepal take their medicines and adopt healthier habits to lower blood pressure.

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment500 (estimated)
SponsorCentral Department of Public Health
Academic / other
Locations2 sites (Kathmandu, Bagmati and 1 other locations)
StatusRecruiting
StartedNovember 2, 2025
Main results expectedDecember 15, 2026
Study endsDecember 31, 2027
Registry record updatedJuly 8, 2026
Trial IDNCT05979168 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with hypertension on blood pressure–lowering meds for at least 3 months with uncontrolled BP who have access to a mobile phone and can read messages.

Probably not a fit

Patients without regular mobile phone access or who have severe comorbidities or cognitive impairment may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a hybrid effectiveness-implementation study that tests a 6-month mobile health intervention delivered via text messages and calls to improve blood pressure, medication adherence, and lifestyle habits among hypertensive adults in Nepal. It uses a parallel randomized controlled design with a qualitative component to understand how the program fits into local care, guided by the RE-AIM framework. The intervention is codesigned with patients, families, and healthcare providers and is evaluated for reach, adoption, fidelity, maintenance, and clinical outcomes at 6 and 12 months. The goal is to see if the approach can be scaled in similar LMIC settings if effective.

Why it matters

Potential benefit: If successful, the program could improve blood pressure control and reduce cardiovascular risk in Nepal and similar LMICs.

How similar studies have gone: Preliminary mobile health pilots in similar settings showed reductions in blood pressure, supporting potential benefit for larger trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Clinical diagnosis of hypertension
* Currently receiving/prescribed blood pressure-lowering medication for more than three months
* With uncontrolled blood pressure (\>130/80mm of Hg)
* Should have access to a mobile phone
* Able to read text messages ( by themselves/with the help of family)

Exclusion Criteria:

* Diagnosed with myocardial infarction, stroke, and kidney failure
* Severe mental illness, cognitive impairment
* Pregnant women or in the postpartum period

Where it's running

  • Sahid Gangalal National Heart Center
    Kathmandu, Bagmati, Nepal
    Recruiting
  • Apara Innovations Pvt Ltd
    Kathmandu, Pradesh 3 (Bagmati), Nepal
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.